Raphael Pharmaceutical Inc.
Disclosed SEC business address
SUITE 105 - 5348 VEGAS DR., LAS VEGAS, NV, 89108
Raphael Pharmaceutical Inc. (ticker RAPH, CIK 0001415397) is tracked by Global Barry from its public SEC filings and disclosures. Disclosed industry classification: Medicinal Chemicals & Botanical Products (SIC 2833). Disclosed business address country: United States. Every item is grounded on the cited public source — no figures are fabricated.
Full evidence detail
Company deep views this month: 1 of 5.
Filing intelligence
50 filings ingested; deep FILING ANALYSIS shown for 8 filings.
- FACT Only one ingested version of this accession exists; no intra-document revisions have been observed. Change tracking for this filing requires ≥2 ingested versions. 2026-09-01 source ↗
- ANALYSIS This 8-K was filed 46 days after the previous ingested 8-K (2026-07-17). 14 filings of this type are ingested. 2026-09-01 source ↗
- UNKNOWN Changed risk-factor language (Item 1A): not derivable from ingested evidence. Current ingestion retains filing metadata, XBRL financial facts, insider-ownership disclosures, and the issuer submission snapshot — not the full filing document body. This item would require ingesting the filing's primary document text. 2026-09-01 source ↗
- UNKNOWN MD&A highlights: not derivable from ingested evidence. Current ingestion retains filing metadata, XBRL financial facts, insider-ownership disclosures, and the issuer submission snapshot — not the full filing document body. This item would require ingesting the filing's primary document text. 2026-09-01 source ↗
- UNKNOWN Material business developments: not derivable from ingested evidence. Current ingestion retains filing metadata, XBRL financial facts, insider-ownership disclosures, and the issuer submission snapshot — not the full filing document body. This item would require ingesting the filing's primary document text. 2026-09-01 source ↗
- UNKNOWN Debt / capital-structure changes: not derivable from ingested evidence. Current ingestion retains filing metadata, XBRL financial facts, insider-ownership disclosures, and the issuer submission snapshot — not the full filing document body. This item would require ingesting the filing's primary document text. 2026-09-01 source ↗
- UNKNOWN Acquisitions / divestitures: not derivable from ingested evidence. Current ingestion retains filing metadata, XBRL financial facts, insider-ownership disclosures, and the issuer submission snapshot — not the full filing document body. This item would require ingesting the filing's primary document text. 2026-09-01 source ↗
- UNKNOWN Litigation / regulatory matters: not derivable from ingested evidence. Current ingestion retains filing metadata, XBRL financial facts, insider-ownership disclosures, and the issuer submission snapshot — not the full filing document body. This item would require ingesting the filing's primary document text. 2026-09-01 source ↗
Latest developments
Most recent SEC filing events ingested for this company (newest first).
- FACT 8-K filed (period 2026-07-30) 2026-09-01 source ↗
- FACT 10-Q filed (period 2026-06-30) 2026-08-14 source ↗
- FACT 8-K filed (period 2026-07-16) 2026-07-17 source ↗
- FACT 10-Q filed (period 2026-03-31) 2026-05-14 source ↗
- FACT 4 filed (period 2025-11-20) 2026-04-06 source ↗
- FACT 10-K filed (period 2025-12-31) 2026-03-31 source ↗
- FACT 8-K filed (period 2025-12-31) 2026-03-24 source ↗
- FACT 10-Q filed (period 2025-09-30) 2025-11-13 source ↗
- FACT 3 filed (period 2025-08-01) 2025-09-08 source ↗
- FACT 10-Q filed (period 2025-06-30) 2025-08-13 source ↗
Insider ownership filings
14 insider ownership filings (Forms 3/4/5) ingested (metadata level).
Geographic footprint (disclosed)
Geographic footprint limited to locations disclosed in ingested evidence.
- FACT Principal executive office (disclosed): LAS VEGAS, NV, 89108
- FACT Mailing address (disclosed): LAS VEGAS, NV, 89108
- FACT State/country of incorporation (disclosed): NV
Industry classification (disclosed)
Industry classification as disclosed by the issuer's SEC record.
- FACT Primary industry (disclosed SIC): Medicinal Chemicals & Botanical Products (SIC 2833)
- FACT SEC filer category: Non-accelerated filer<br>Smaller reporting company
Supply chain
No supplier or customer relationships are disclosed in ingested evidence. Supply-chain relationships are shown only when explicitly disclosed and cited; undisclosed relationships are never inferred.
- UNKNOWN No supplier or customer relationships are disclosed in ingested evidence. Supply-chain relationships are shown only when explicitly disclosed and cited; undisclosed relationships are never inferred.
Risk factors
Risk-factor language requires ingested filing document bodies.
- UNKNOWN Risk-factor language requires ingested filing document bodies.
Sources
- U.S. Securities and Exchange Commission, EDGAR · filing index · retrieved 2026-10-19T23:41:28.200998+00:00
- SEC EDGAR · issuer filing index
Grounded on public SEC filings and disclosures with explicit evidence tiers and citations. This page is informational only and is not investment advice. No figures are fabricated; unavailable data is shown as unavailable.